Myriad Genetics (MYGN): FQ4 EPS of $0.24 beats by $0.02. Revenue of $86M (+33%) vs. $87M. Shares...

|About: Myriad Genetics, Inc. (MYGN)|By:, SA News Editor
Myriad Genetics (MYGN): FQ4 EPS of $0.24 beats by $0.02. Revenue of $86M (+33%) vs. $87M. Shares +6.8% AH. (PR)